Thor Knak Jensen

Odense University Hospital

Papers

1

Total Citations

5

H-Index

1

About

Thor Knak Jensen is a leading urologic surgeon and researcher whose work centers on improving outcomes in robot-assisted radical cystectomy for bladder cancer patients. His primary research areas include surgical technique innovation, postoperative complication reduction, and the prevention of ureteroenteric strictures—a common and debilitating complication following bladder removal. Jensen’s most notable contribution is the MOSAIC randomized controlled trial (DaBlaCa-16), which investigates the retrosigmoid ileal conduit as a novel approach to lower the high rate of benign strictures, particularly in the left ureter. This feasibility study, published in 2024 with 5 citations, has already sparked significant interest in the urologic community for its potential to improve patient quality of life. By challenging the conventional ileal conduit technique, Jensen is addressing a critical gap in surgical practice. His work demonstrates a commitment to evidence-based innovation, and the MOSAIC trial positions him as a key figure in advancing robotic cystectomy outcomes. For students and researchers, Jensen’s research exemplifies how thoughtful surgical modifications can tackle persistent clinical challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
DaBlaCa-16: Retrosigmoid Versus Conventional Ileal Conduit in Robot-assisted Radical Cystectomy, the MOSAIC Randomized Controlled Trial—Feasibility and 90-day Postoperative Complications
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Odense University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago